What is the market doing?
What the tape says about MLTX
MoonLake Immunotherapeutics is −70% over the past year while the S&P 500 is +23%: 92 points behind the market.
−70%
1-year return · S&P 500 +23%
- vs 200-day average
- −3.9%
vs 200-day average · below trend, but not far
- RSI (14)
- 28
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- −75%
Below its 52-week high
Details›
- Last close2026-08-26
- $15.61
- 1 monthS&P 500 +3.7%
- −20%
- 1 yearS&P 500 +23%
- −70%
- 5 yearsS&P 500 +87%
- +57%
- vs 50-day average$18.31
- −15%
- 52-week high
- $61.99
- 52-week low
- $6.24
- Annualised volatility
- 91%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$66M
| Year | Return |
|---|---|
| 2026 (year to date) | +18% |
| 2025 | −76% |
| 2024 | −10% |
| 2023 | +475% |
| 2022 | +6.2% |
| 2021 | −13% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 2 of 6 | +1.1% |
| Feb | 6 | 3 of 6 | +8.4% |
| Mar | 6 | 4 of 6 | +3.3% |
| Apr | 6 | 1 of 6 | −11% |
| May | 6 | 3 of 6 | +10% |
| Jun | 6 | 5 of 6 | +15% |
| Jul | 6 | 3 of 6 | +5.0% |
| Aug | 6 | 3 of 6 | +4.8% |
| Sep | 5 | 2 of 5 | −17% |
| Oct | 5 | 3 of 5 | +6.1% |
| Nov | 6 | 4 of 6 | +9.9% |
| Dec | 6 | 3 of 6 | +7.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.